How do I interpret my genomic profiling results for Lymphoma
Understanding Your Lymphoma Genomic Profiling Results
Genomic profiling is an important test that looks at the DNA changes in your lymphoma cells. Let me walk you through how to interpret these results and what they mean for your care.
What Genomic Profiling Does
Genomic profiling examines the genetic mutations (changes in DNA) that are unique to your cancer cells. According to the NCCN Guidelines for Marginal Zone Lymphomas, these DNA changes can affect your diagnosis, treatment options, and prognosis. Think of it like reading an instruction manual for your cancer cells—it tells doctors what "mistakes" are in the genetic code that's driving the cancer.
Types of Genetic Changes You Might See
Your report may describe several types of mutations:
- Deletion – When part of a chromosome or gene is missing
- Amplification – When part or whole of a chromosome or gene is increased (duplicated)
- Translocation or rearrangement – When parts switch between two chromosomes
- Point mutation – When a single part of a gene is changed
- Insertion – When a new part of a chromosome or gene is included
How Results Are Reported
You'll likely see results written with plus (+) or minus (-) signs:
- CD20+ means the protein CD20 was found on the cancer cells
- CD10- means the protein CD10 was NOT found
These patterns help your doctor classify your specific lymphoma type and determine which treatments might work best.
Why This Matters for Treatment
Some mutations can be targeted with specific therapies. This is crucial—it means your doctor can potentially choose treatments designed to attack the specific genetic weaknesses in YOUR cancer cells. According to the NCCN Guidelines, mutation testing is also used to look for new mutations that may develop during treatment, which can sometimes lead to drug resistance.
Important Questions to Ask Your Doctor
Since genomic profiling results are complex and personalized to your situation, here are specific questions to discuss with your care team:
-
"What specific mutations or genetic changes were found in my lymphoma cells?" (Ask them to explain each one in plain language)
-
"Do any of these mutations have targeted therapies available, and would they be appropriate for me?"
-
"How do these results affect my treatment options and prognosis?"
-
"Will you repeat this testing during or after treatment to check for new mutations?"
-
"Are there any clinical trials available based on my specific genetic profile?"
Important Context
While genomic profiling provides valuable information, your complete clinical picture matters too. Your doctor will consider:
- Your lymphoma stage and type
- Your overall health and fitness for treatment
- Other test results (imaging, blood work, bone marrow biopsy if done)
- Your personal preferences and goals
Your oncologist will determine the most appropriate treatment approach based on ALL of this information together, not just the genomic results alone.
Getting More Information
The Lymphoma Research Foundation (lymphoma.org) and National Cancer Institute (NCI) have excellent patient-friendly resources about lymphoma genetics and treatment options. You can also ask your care team if your specific mutations are discussed in NCCN Guidelines for your lymphoma subtype.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 17, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- Which biomarker tests (CD20, PD-L1) are recommended for my Lymphoma, and how will the results guide my diagnosis and...
- Got biopsy results and its Hodgkin's Lymphoma. I am literally breaking down. Don't see how my family will hold. Not...
- After many long weeks, finally an update. The results of the tests: the cancerous cells are in the bone marrow, the...
- Start my Rituximab treatments on Monday. Glad they are finally getting on with it. How many have had lasting results...
- Hello! Recently had an ultrasound and mammogram upon finding a lump under my armpit. The results from the...
- I rang to get my biopsy results today but the secretary said they are too complicated to read over the phone. Does...
- Recent CT Results -- What should I ask for? Been having every 6mos since they showed up a little over year ago....
- What does progression mean for Lymphoma and what happens next